Publikationen, an denen er mitarbeitet Diego Martínez Urbistondo (26)

2024

  1. Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks

    Current Obesity Reports, Vol. 13, Núm. 3, pp. 461-474

2023

  1. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

    Biomedicine and Pharmacotherapy, Vol. 161

  2. Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)

    Frontiers in Endocrinology

  3. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset

    European Journal of Clinical Investigation, Vol. 53, Núm. 10

  4. Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort

    Frontiers in Endocrinology, Vol. 13

2022

  1. Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine

    Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 25, Núm. 5, pp. 285-291

  2. Hematological-and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events

    Journal of Clinical Medicine, Vol. 11, Núm. 17

  4. Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome

    Frontiers in Nutrition, Vol. 9

  5. Longwise Cluster Analysis for the Prediction of COVID-19 Severity within 72 h of Admission: COVID-DATA-SAVE-LIFES Cohort

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  6. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases

    World Journal of Gastroenterology, Vol. 28, Núm. 44, pp. 6230-6248

  7. Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

    Frontiers in Endocrinology, Vol. 13

  8. Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort

    Frontiers in Endocrinology, Vol. 13

  9. The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management

    Current Obesity Reports, Vol. 11, Núm. 4, pp. 305-335

2021

  1. Interactions of comorbidity and five simple environmental unhealthy habits concerning physical and mental quality of life in the clinical setting

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 18

  2. Proinflammatory and hepatic features related to morbidity and fatal outcomes in covid-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Antioxidant lifestyle, Co-morbidities and quality of life empowerment concerning liver fibrosis

    Antioxidants, Vol. 9, Núm. 11, pp. 1-13

  2. Cardiovascular risk, Metabolic disease and NASH control for Health Empowerment: Future endeavours

    Clínica e investigación en arteriosclerosis, Vol. 32, Núm. 5, pp. 206-208

  3. Control del riesgo cardiovascular, la enfermedad metabólica y la esteatosis hepática a través del empoderamiento de la salud: una propuesta de futuro

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 5, pp. 206-208

  4. Cross-sectional evaluation of the interaction between activity relative-time expenditure and comorbidity concerning physical quality of life

    Medicine, Vol. 99, Núm. 48, pp. e22552